The University of Kansas Cancer Center Blog
Read up on the latest in cancer care, including cancer prevention, cancer research and innovations in cancer treatment.
Aggressive Treatment for Aggressive Abdominal Cancers: CRS-HIPEC
By Mazin Al-kasspooles, MD, surgical oncologist
A Researcher's Guide to the Cancer Biology Program
The cancer center’s research programs – Cancer Biology, Cancer Prevention and Control and Drug Discovery, Delivery and Experimental Therapeutics - bring together investigators who share mutual interests and goals.
Remembering patient research advocate Doug Sparling
An author, artist, musician and technology guru, Doug ultimately found his calling as a cancer research advocate.
5 Things You May Not Know About Clinical Trials
With all the advances in our understanding of cancer biology and new options for treatment, today is an ideal time to consider joining a clinical trial.
Artificial Intelligence in Cancer Screening
Scientists are exploring the use of AI in cancer screenings
Find a Researcher Tool
The University of Kansas Cancer Center’s Find a Researcher tool lets you search for scientists with specific expertise and identify potential research collaborations.
The future of pancreatic cancer treatment: It’s personal
As pancreatic cancer survival rates inch upward, Dr. Anup Kasi is committed to continuing his urgent journey to find more effective, personalized treatments.
Why Question Cancer?
By Michelle Hills, Community Advisory Board Member, The University of Kansas Cancer Center
Using Data to Take on Cancer
The University of Kansas Cancer Center members built a data platform to streamline the process of synthesizing data about Kansas and Missouri demographics, cancer risk factors and incidence, and mortality rates.
Exploring Immunotherapy Treatments to Treat Brain Cancer
Research offers hope for this difficult-to-treat disease.
Children's Mercy Joins Pediatric Early Phase Clinical Trials Network
Children’s Mercy has been designated a non-core member of the Pediatric Early Phase Clinical Trials Network (PEP-CTN), enhancing their ability to bring the latest leading-edge pediatric cancer clinical trials to our region.
The Next Chapter in Immunotherapy Research
By Joseph McGuirk, DO, director of The University of Kansas Cancer Center’s Hematologic Malignancies and Cellular Therapeutics program
Can You Prevent Pancreatic Cancer?
Pancreatic cancer is a rare and deadly type of cancer with poor survival. It has the 3rd-lowest survival rate of all types of cancer. The American Cancer Society estimates 57,600 people will be diagnosed with pancreatic cancer in 2020. There is no w...
Why I Got the COVID-19 Vaccine
Dr. Roy Jensen, director of KU Cancer Center, shares why he got the COVID-19 vaccine.
COVID-19 Vaccine FAQs for Cancer Patients
Patients with cancer are particularly vulnerable to COVID-19 because of the immunocompromising nature of cancer treatments. And while the arrival of vaccines gives us hope, it also leads to confusion among cancer patients. Here, we try to address som...